Risk factors of mortality in COVID-19 patients Phaholpolpayuhasena Hospital Kanchanaburi
Abstract
The COVID-19 pandemic is spreading rapidly across the world. COVID-19 severely affected trade,economy, and public health system. Death rate of COVID-19is higher than that of other respiratory diseases. Therefore, we conducted a study to identify risk factors related to mortality in patients with COVID-19 in Phaholpolpayuhasena Hospital.
The results found that the risk factors for death of COVID-19 patients at Phaholpolpayuhasena Hospital were consistent with other studies, including male patients, elderpatientand those with underlying diseases. Therefore, this group of patients need special attention. Clinical features that showed poor prognosis in COVID-19 include high fever and presence of pneumonitis. Even, the mortality rate was not different in vaccination patients, vaccination and booster vaccination is still recommend, because the limitation of retrospective study and types of vaccines in this study did not include mRNA vaccines.
References
Prevention CoDCa. www.cdc.gov. [Online]; 2022. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/testing/index.html.
Carter LJ GLVSJLYZQSCea. Assay techniques and test development for COVID-19 diagnosis. ACS Central Science. 2020;: p. 6:591–605.
Mardian Y KHKMNAaLCY. Review of Current COVID-19 Diagnostics and Opportunities for Further Development. Frontiers in Medicine. 2021;: p. 8:615099.
Guan W NZHYLWOCHJea. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020;: p. 382:1708–20.
Zoabi Y DRSSN. Machine learning-based prediction of COVID-19 diagnosis based on symptoms. npj Digital Medicine. 2021;: p. 4:3.
Sitthichai B, Phisan C. Case Fatal Rate and Factors Associated with Deaths due to COVID-19. Journal of Research for Health Improvement and Quality of Life. 2022;: p. 25-36.
Kaeuffer C LHCFTea. Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020. Eurosurveillance. 2020;: p. 25(48):2000895. doi: 10.2807/1560-7917.ES.2020.25.48.2000895. PMID: 33272355; PMCID: PMC7716399.
Figliozzi S MPANTLKEAAea. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. European journal of clinical investigation. 2020;: p. Oct;50(10):e13362.
Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions. MMWR. 2022;: p.71:132–138. DOI:
http://dx.doi.org/10.15585/mmwr.mm7104e2.
Sanne de Bruin LDBMAvRea. Clinical features and prognostic factors in Covid-19: A prospective cohort study. eBioMedicine. 2021;: p. May 13, 2021. DOI: https://doi.org/10.1016/j.ebiom.2021.103378.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Phaholpolpayuhasena Hospital
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของโรงพยาบาลพหลพลพยุหเสนา
ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับโรงพยาบาลพหลพลพยุหเสนาและบุคลากรท่านอื่น ๆ ในโรงพยาบาลฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเอง
Phaholpolpayuhasena Hospital